HealthRX.com · Printable question sheet
Birth control review before starting or increasing Mounjaro
Take this to the visit where Mounjaro is started or a dose goes up. It records the method you use and how you take it, your pregnancy plans and any change in your cycles, and the date each label backup period ends, with the label's own facts and the questions worth asking.
Methods you use now
- Combined pill (estrogen and progestin)
- Progestin-only pill
- Skin patch
- Vaginal ring
- Hormonal IUD
- Copper IUD
- Implant
- Contraceptive injection
- Condoms or a diaphragm
- No method at the moment
Your situation
Pill name and the time of day you take it
Mounjaro start date
Pregnancy plansnone, within a year, unsure
Periods since startingmore regular, less regular, unchanged
Emergency contraception you would use if needed
What the Mounjaro label says
- Mounjaro may make birth control pills less effective because it slows stomach emptying.[1]
- With a pill, switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase.[1]
- Hormonal methods that are not taken by mouth should not be affected.[1]
- In the label's study, a first 5 mg dose lowered the pill hormones' peak levels by 55% to 66% and their total exposure by 20% to 23%.[1]
- Tell your prescriber if you are pregnant or intend to become pregnant.[1]
Backup periods
| Start or increase date | New weekly dose (mg) | Backup or non-oral method until | Missed or late pills | Vomited within a few hours of a pill |
|---|---|---|---|---|
Questions for the prescriber
- Would an IUD, implant, injection, patch or ring suit me better while my dose is changing?
- If I stay on the pill, which barrier method should I use, and until which date after each increase?
- What should I do if I vomit soon after taking a pill?
- Which emergency contraception would work best for me if I needed it?
- Does my progestin-only pill need anything different?
- If I want to become pregnant, when should Mounjaro stop?
Sources for the facts on this sheet
- Eli Lilly and Company, via DailyMed. Mounjaro (tirzepatide) injection, for subcutaneous use: prescribing information and Medication Guide. Effective 2026-08-27. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.